Heart Disease & COVID-19 Are a Dangerous Mix for EU Patients
The COVID-19 pandemic is making cardiovascular disease still more deadly for patients, a recent statement from Members of the European Parliament confirms.
Los latinoamericanos con cáncer enfrentan brechas en la atención
Los pacientes con cáncer pueden ser más vulnerables al COVID-19 y tener un mayor riesgo de desarrollar complicaciones graves si están infectados.
Latin Americans with Cancer Face Gaps in Care
Cancer patients can be more vulnerable to COVID-19 and at greater risk of developing serious complications if they are infected.
Setting the Record Straight on COVID-19 Vaccines
European citizens have questions about the COVID-19 vaccines. Are they safe? Will they work? What about side effects? Answers to those questions are emerging, in part due to the efforts of the European Medicines Agency.
Pandemic Challenges Shake Europeans with Rare Diseases
European citizens with rare diseases are struggling to maintain treatment during the COVID-19 pandemic, a new report explains.
Empowering Patients in the Value Debate
Patients need a more meaningful role in decisions about the value of medications, a new report from the Global Alliance for Patient Access explains.
Arthritis & the European Workforce
Effectively treating rheumatic and musculoskeletal diseases doesn’t just serve patients. It also benefits Europe’s workplaces.
European Patient Groups Call for HTA Improvements
The COVID-19 pandemic has made one point clear for advocates: Health technology assessments across Europe could work better and more efficiently.
Cardiovascular Advocates Elevate Global Call to Action
Reaching consensus is a challenge for any community, and the global health care community is no exception.
Non-Communicable Disease Treatment Falters Under COVID-19
According to new research from the World Health Organization, the treatment and prevention of non-communicable diseases have been “severely disrupted” since the pandemic began.
